Mode
Text Size
Log in / Sign up
N/A N=132 Randomized Double-blind Health Services Research

Prolonged Exposure (PE) for Post Traumatic Stress Disorder (PTSD): Telemedicine Versus In Person

PTSD

Enrolled (actual)
132
Serious AEs
0.7%
Results posted
Sep 2016
Primary outcome: Primary: Treatment Completion — 7.6; 8.6; 3.1; 2.9 sessions

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Telemedicine (Behavioral); In Person (Behavioral)
Age
Adult, Older Adult · 21+ yrs
Sex
All
Sponsor
VA Office of Research and Development
Primary completion
Jun 2015

Outcome Measures

OutcomeResultp-value
PRIMARY
Treatment Completion
7.6; 8.6; 3.1; 2.9
PRIMARY
PTSD Checklist-Military (PCL-M)
64; 61.8; 48.4; 44.9; 49.2; 46.5
PRIMARY
Beck Depression Inventory-II (BDI-II)
28.0; 27.4; 21.7; 19.6; 18.3; 17.6
SECONDARY
Clinician Administered PTSD Scale for DSM-IV (CAPS IV)
68.4; 68.2; 41.9; 41.1; 41.0; 38.7
SECONDARY
Deployment Risk and Resiliency Inventory (DRRI)
SECONDARY
Health Related Functioning: Medical Outcome Study (MOS) Short Study Forms-36 Health Survey (SF 36)
18.60; 10.90; 17.90; 19.00; 15.00; 12.90
SECONDARY
Charleston Psychiatric Outpatient Satisfaction Scale (CPOSS-VA)
65.6; 65.5
SECONDARY
Treatment Credibility
4.4; 4.5
SECONDARY
Service Delivery Perceptions Questionnaire
4.6; 4.7
SECONDARY
Structured Clinical Interview for DSM-IV (SCID-I)
75.6; 86.5; 66.7; 52.9; 58.3; 40.0
SECONDARY
Prior Experience With Computer and Audiovisual Technology

Summary

The present proposal is to study whether Prolonged Exposure (PE) delivered via Telemedicine is as effective as PE delivered In Person for Operation Iraqi Freedom (OIF), Operation Enduring Freedom (OEF) Veterans and Veterans of all theatres, particularly Vietnam era with Post-Traumatic Stress Disorder (PTSD). ).

Eligibility Criteria

Inclusion Criteria

Participants will be 226 male and female:

  • Operation Iraqi Freedom, Operation Enduring Freedom (OIF OEF) Veterans, and Veterans of all theatres, particularly Vietnam era Veterans.
  • age 21 and above, and
  • diagnosed via structured clinical interview with PTSD

Exclusion Criteria

  • Actively psychotic or demented persons,
  • individuals with both suicidal ideation and clear intent, and
  • individuals meeting full criteria for substance dependence will be excluded from participation
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01102764). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search